IntegriChain, delivering pharma’s only comprehensive technology, data, consulting, and outsourcing platform for data-driven commercialization, today announced the appointment of Joshua Halpern, co-founder and current President and Chief Operating Officer, to the role of Chief Executive Officer (CEO) effective February 1, 2023. Kevin Leininger, current CEO, will transition to the role of Executive Chairman and remain active in the business strategy. In addition, Sachin Sadekar has been promoted to Senior Vice President and Managing Director, India Operations, and Jeff Tanner has been promoted to Senior Vice President of Solution Delivery, also effective February 1, 2023.
“Over the last two years, IntegriChain has made incredible strides in our growth trajectory and ability to deliver solutions that overcome key commercialization challenges for our pharma customers, and we owe so much of our success to Kevin’s leadership,” said Halpern. “We’ve created the first comprehensive platform for data-driven drug commercialization and access; we’ve become the industry’s largest provider of Contracts & Pricing managed services; we’ve amassed an outstanding team of world-class strategic consultants and hands-on operational consultants that spans the full spectrum of drug commercialization; we’ve built innovative data and technology solutions that are used in the day-to-day operations of more than 250 manufacturers; and we’ve become a highly visible and impactful company in the pharma commercial services market. I am forever indebted to Kevin as my mentor and partner. I’m excited about IntegriChain’s future as we begin our next chapter and look forward to helping the company achieve its next set of objectives in my new role.”
“Josh and I founded IntegriChain 16 years ago and have led the company’s growth side by side,” said Leininger. “He truly understands the challenges that pharma manufacturers face and has played a vital role in delivering a transformative data, technology, service, and consulting platform to the industry. I am proud of the outstanding team that will take IntegriChain forward, I am utterly confident in Josh’s ability to seamlessly lead IntegriChain to the next level, and I consider myself lucky to continue to play an important role on the board going forward.”
Josh Halpern co-founded IntegriChain in 2006 and brings more than 20 years of experience in pharmaceutical commercialization, data, and analytics. As the company’s Chief Executive Officer, he will be responsible for corporate management and leadership of IntegriChain’s global workforce and strategic planning for the company, focusing on driving long-term business value across the company’s operations, its go-to-market strategy and teams, and its technology organization and roadmaps. From IntegriChain’s founding through its initial venture capital-backed growth, Halpern led the development of IntegriChain’s market leading channel and patient data aggregation solutions. Following the company’s partnership with Accel-KKR in 2016, Halpern has been a key leader in five successful acquisitions and their integration within the IntegriChain business and IntegriChain’s ICyte technology platform. In that time, IntegriChain has grown to become a visionary technology, data, consulting, and outsourcing platform for data-driven drug commercialization with more than 600 team members and 400 customers. Halpern is a frequent industry speaker and author on data-driven strategies for patient access and therapy commercialization. He earned his bachelor’s degree at Princeton University.
